| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +60.00% | +0.15% | -0.47% | +0.62% | -8.30% | — |
| 14d | 5 | +60.00% | +0.74% | -1.00% | +1.73% | -9.37% | — |
| 30d | 5 | +80.00% | -6.93% | -0.49% | -6.44% | -15.05% | — |
| 60d | 5 | +60.00% | -2.44% | +2.90% | -5.34% | -7.41% | — |
| 90d | 5(1 pending) | +75.00% | -9.74% | +2.04% | -6.84% | -19.10% | — |
| 180d | 5(3 pending) | +50.00% | -2.13% | +8.27% | -10.40% | -10.40% | — |
| 1y | 5(5 pending) | — | — | — | — | — | — |
| 2y | 5(5 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 2,437 | — | — | 78,001 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 2,437 | $15.00 | $36.6K | 2,438 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 2,438 | $15.02 | $36.6K | 0 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 2,438 | — | — | 75,563 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 2,438 | $8.26 | $20.1K | 4,875 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 2,437 | $8.26 | $20.1K | 2,437 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 2,437 | — | — | 80,438 | Apr 17, 2026 | Apr 20, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 2,437 | $15.00 | $36.6K | 0 | Apr 17, 2026 | Apr 20, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 2,437 | $8.26 | $20.1K | 2,437 | Apr 17, 2026 | Apr 20, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 2,438 | $17.87 | $43.6K | 0 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 2,438 | $8.26 | $20.1K | 2,438 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 2,438 | — | — | 82,875 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 2,437 | — | — | 85,313 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 2,437 | $15.00 | $36.6K | 0 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 2,437 | $8.26 | $20.1K | 2,437 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 29,250 | — | — | 87,750 | Jan 5, 2026 | Jan 7, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 42,544 | $17.10 | $727.3K | 0 | Jan 5, 2026 | Jan 7, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 29,250 | $8.26 | $241.6K | 42,544 | Jan 5, 2026 | Jan 7, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE Chief Medical Officer | 19,667 | — | — | 19,667 | Jan 3, 2026 | Jan 6, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 6,373 | $17.48 | $111.4K | 13,294 | Jan 3, 2026 | Jan 6, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE Chief Medical Officer | 19,667 | — | — | 39,333 | Jan 3, 2026 | Jan 6, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASEGRANT Stock grant | 85,700 | — | — | 85,700 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASEGRANT Stock grant | 171,400 | — | — | 171,400 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE10b5-1 10b5-1 plan | 2,722 | $11.61 | $31.6K | 0 | Nov 11, 2025 | Nov 12, 2025 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASEGRANT Stock grant | 117,000 | — | — | 117,000 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASEGRANT Stock grant | 59,000 | — | — | 59,000 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |